Table 6.
Recurrences of perineal endometriosis after initial treatment.
| Number of patients | ASI | Initial treatment | Follow-up (months) | |||
|---|---|---|---|---|---|---|
| Surgical | Hormonal | Duration | ||||
| Prince et al. (41) | 1 | No | Excision | No | NA | 6 |
| Trampuz et al. (76) | 1 | yes | Excision | No | NA | 3 |
| Swerdlow et al. (69) | 1 | No | TAH + BSO | No | NA | 3 |
| Gordon et al. (22) | 1 | yes | Excision | No | NA | 5 |
| Liang et al. (2) | 1 | NA | Excision | No | NA | 12 |
| Kahraman et al. (38) | 1 | No | CE | Oral contraceptives | NA | 3 |
| Nominato et al. (92) | 1 | NA | Excision | No | NA | NA |
| Eyvazzadeh et al. (19) | 1 | No | Biopsy | No | NA | 60 |
| Iqbal et al. (28) | 1 | No | Incision and drainage | No | NA | 6 |
| Zhu et al. (93) | 7 | Yes | IE | GnRHa pre or post op | 3–6 months | 4–12 |
| 1 | NA | CE | Postop contraceptive pills 17alpha-hydroxyprogesterone caproate 250 mg intramuscular injection per 28 days and tamoxifen 10 mg twice a day for 8 months | 8 months | 84 | |
| Chen et al. (10) | 1 | Yes | NE | GnRHa Pre-op | 3 months | 12 |
| 1 | Yes | IE | DMPA pre- and post-op | 3–6 months | 72 | |
| Jain et al. (32) | 2 | No | Excision | No | NA | 3–7 |
| Grimstad et al. (24) | 1 | No (clitoris) | Excision | Oral contraceptives | NA | 72 |
| Li et al. (94) | 1 | NA | CE | GnRH | 3 | 12 |
| Matalliotakis et al. (95) | 2 | NA | Excision | NA | NA | NA |
| Liu et al. (96) | 3 | No | CE | No | NA | 12–36 |
| 1 | No | CE | GnRHa post-op | 3 months | 12 | |
| 29 | ||||||
IE, incomplete excision; CE, complete excision; NE, narrow excision; TAH + BSO, total abdominal hysterectomy + bilateral salpingo-oophorectomy; GnRHA, gonadotropin-releasing hormone analog; DMPA, Depot medoxyprogesterone acetate; NA, not available.